Form 4: Elite Health Systems CEO Acquires 250,000 Shares in Stock Grant

Sentiment:

SEC Form 4 Filing


Elite Health Systems CEO, Prasad Anjaneya Jeereddi, acquired 250,000 shares of common stock as part of a grant for past and future services.

Summary

  • Prasad Anjaneya Jeereddi, CEO of Elite Health Systems Inc., acquired 250,000 shares of the company's common stock on November 29, 2024.
  • The shares were granted as compensation for past and future services to the company and were fully vested on the date of the grant.
  • Following the transaction, Mr. Jeereddi directly owns 1,528,983 shares and indirectly owns 222,114 shares through an entity where he is a managing member and major equity owner.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

  • The grant of shares to the CEO aligns his interests with the company's performance.
  • The vesting of the shares on the grant date indicates immediate ownership and commitment.

Industry Context

This type of stock grant is a common practice for compensating executives in publicly traded companies, aligning their interests with shareholder value.

Comparison to Industry Standards

  • Stock grants are a standard form of executive compensation, often used by companies like UnitedHealth Group (UNH) and CVS Health (CVS) to incentivize performance.
  • The size of the grant, 250,000 shares, would need to be compared to similar grants at companies of comparable size and market capitalization to determine if it is within industry norms.
  • The vesting terms, fully vested on the grant date, are less common than phased vesting schedules, which are often used to retain executives over a longer period.

Related Party Transactions

  • The CEO's indirect ownership of 222,114 shares through an entity where he is a managing member and major equity owner is a related party transaction.

Stakeholder Impact

  • Shareholders may view the stock grant positively as it incentivizes the CEO to improve company performance.
  • The grant does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
11/29/2024Date of the stock grant and vesting.
12/02/2024Date of the SEC filing.

Keywords

stock grant, insider trading, share ownership, executive compensation, common stock, Elite Health Systems, USNU, Prasad Anjaneya Jeereddi

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.